Your Health, We Care
The indications of Afatinib continue to expand, including the treatment of HER2 positive patients with advanced breast cancer, and patients with advanced lung squamous cell carcinoma after first-line chemotherapy.
The FDA has also approved Afatinib for the treatment of metastatic NSCLC patients carrying uncommon EGFR mutations (L861Q, G719X, and/or S768I).
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
